Exelixis, Inc. (EXEL)
41.53
+0.25
(+0.61%)
USD |
NASDAQ |
Mar 06, 16:00
41.74
+0.21
(+0.51%)
After-Hours: 20:00
Exelixis Market Cap : 10.79B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 27.59B |
| Merck & Co., Inc. | 286.28B |
| Gilead Sciences, Inc. | 178.74B |
| Castle Biosciences, Inc. | 807.20M |
| Agenus, Inc. | 107.34M |
Market Cap Related Metrics
| PE Ratio | 14.92 |
| PS Ratio | 5.045 |
| PEG Ratio | 0.2615 |
| Price to Book Value | 4.990 |
| Price to Free Cash Flow | 13.37 |
| Price | 41.53 |
| Earnings Yield | 6.70% |
| PEGY Ratio | 0.2615 |
| Operating PE Ratio | 13.11 |
| Normalized PE Ratio | 14.65 |